scholarly article | Q13442814 |
P356 | DOI | 10.1002/CPT.998 |
P698 | PubMed publication ID | 29271001 |
P2093 | author name string | Jenny Y Chien | |
Stephan Schmidt | |||
Puneet Gaitonde | |||
Parag Garhyan | |||
Felipe K Hurtado | |||
P2860 | cites work | Deteriorating beta-cell function in type 2 diabetes: a long-term model | Q44372257 |
Mathematical models of diabetes progression | Q44864538 | ||
A mechanism-based disease progression model for comparison of long-term effects of pioglitazone, metformin and gliclazide on disease processes underlying Type 2 Diabetes Mellitus. | Q51501369 | ||
Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study. | Q51570046 | ||
Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM | Q77296898 | ||
Disease system analysis: basic disease progression models in degenerative disease | Q80390429 | ||
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
Use and abuse of HOMA modeling | Q28263292 | ||
Analysis of combination drug therapy to develop regimens with shortened duration of treatment for tuberculosis | Q28540482 | ||
Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models | Q30499990 | ||
Application of a mechanism-based disease systems model for osteoporosis to clinical data | Q34546981 | ||
Beta-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities | Q34996991 | ||
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes | Q35085591 | ||
Evaluation of the long-term durability and glycemic control of fasting plasma glucose and glycosylated hemoglobin for pioglitazone in Japanese patients with type 2 diabetes. | Q35138216 | ||
Coping with time scales in disease systems analysis: application to bone remodeling | Q35591581 | ||
Pathogenesis of type 2 diabetes mellitus | Q35861736 | ||
Diagnosing model diagnostics | Q36850144 | ||
Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Q37141727 | ||
Systems approaches in risk assessment. | Q38093360 | ||
Future glucose-lowering drugs for type 2 diabetes. | Q38711383 | ||
Modeling and Simulation Workbench for NONMEM: Tutorial on Pirana, PsN, and Xpose | Q41454681 | ||
A model for glucose, insulin, and beta-cell dynamics in subjects with insulin resistance and patients with type 2 diabetes | Q43059458 | ||
P407 | language of work or name | English | Q1860 |
P577 | publication date | 2017-12-22 | |
P1433 | published in | Clinical Pharmacology & Therapeutics | Q1101529 |
P1476 | title | Development and Qualification of a Drug-Disease Modeling Platform to Characterize Clinically Relevant Endpoints in Type 2 Diabetes Trials |
Search more.